Why One Korean Biotech Picked New Jersey for U.S. Headquarters

Article

Pharmaceutical Executive

New Jersey is still a top pick for companies when it comes to pharma.

Ki-Young Sohn, chairman and CEO of Enzychem Lifesciences, explains why the company selected New Jersey as the location for their U.S. offices.

He spoke to Pharm Exec during a company event in New York City.

 

Recent Videos
John Arena
James Foster
John Arena
James Foster
Navigating an Uncertain Regulatory Landscape
James Foster
Related Content
Navigating the EU’s Joint Clinical Assessment

Navigating the EU’s Joint Clinical Assessment

Ruairi O’Donnell, PhD
February 13th 2025
Article

Pathways to success for this key component of Europe’s new HTA regulation, where thinking beyond the purely technical will be critical.

Navigating Cross-Border Pharma Deals: Key Trends and Lessons Out of China

Navigating Cross-Border Pharma Deals: Key Trends and Lessons Out of China

Bruce Liu;Martin Slusarczyk, PhD;Selene Peng;Joki Wallace
February 12th 2025
Article

The importance of a strategic approach and proper due diligence in unlocking the full potential of these arrangements.

Exploring Biopharma's Dealmaking Terrain, Roadmap in China

Exploring Biopharma's Dealmaking Terrain, Roadmap in China

Adam Zhang Yu
January 27th 2025
Article

A surge in biotech startup out-licensing deals from the country are paving the way for increased IPO and M&A activities.

Pharma Forecasting: Key Markets Investors Can’t Ignore

Pharma Forecasting: Key Markets Investors Can’t Ignore

Na Wei;Joerg Tritschler;Martin Slusarczyk, PhD
December 13th 2024
Article

The importance of expanding your pharma sales forecasting horizon beyond the US. Learn how to effectively navigate country-specific regulatory red flags.

Passage to Asia: Early Access for Innovative Therapies

Passage to Asia: Early Access for Innovative Therapies

Bruce Liu
November 13th 2024
Article

Pharma looks to take advantage of expanded access programs across Asia-Pacific region.

Mike Ryan

Global Expansion: Q&A with Mike Ryan

Mike Hollan
November 13th 2024
Article

EVERSANA's Ryan discusses the company’s recent expansion into new markets in Europe.